Skip to main content

Dimensional Fund Advisors LP

SEC CIK
0000354204
Latest filing
Aug 11, 2026

SCPH holding history

scPharmaceuticals Inc. in every 13F filed by Dimensional Fund Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SCPH overviewAll 13F holders of SCPHFull Q2 2026 holdings

Shares (Q4 2024)
0
Sold out in Q4 2024
Value
$0
% of portfolio
0.0%
Quarters held
15
Since Q1 2021
Holdings of SCPH by Dimensional Fund Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20240$00.0%−33,152−100.0%Sold outHolders
Q3 202433,152$151.3K<0.1%−101,928−75.5%ReducedHolders
Q2 2024135,080$587.6K<0.1%−31,136−18.7%ReducedHolders
Q1 2024166,216$834.4K<0.1%−7,357−4.2%ReducedHolders
Q4 2023173,573$1.09M<0.1%−27,230−13.6%ReducedHolders
Q3 2023200,803$1.43M<0.1%−6,470−3.1%ReducedHolders
Q2 2023207,273$2.11M<0.1%00.0%UnchangedHolders
Q1 2023207,273$1.88M<0.1%−7,965−3.7%ReducedHolders
Q4 2022215,238$1.54M<0.1%+76,119+54.7%AddedHolders
Q3 2022139,119$906.0K<0.1%+22,677+19.5%AddedHolders
Q2 2022116,442$561.0K<0.1%+12,908+12.5%AddedHolders
Q1 2022103,534$588.0K<0.1%+6,787+7.0%AddedHolders
Q4 202196,747$485.0K<0.1%+17,482+22.1%AddedHolders
Q3 202179,265$527.0K<0.1%+34,438+76.8%AddedHolders
Q2 202144,827$273.0K<0.1%−2,051−4.4%ReducedHolders
Q1 202146,878$311.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.